VIVUS (VVUS) Resumes Trading +17%
Tweet Send to a FriendGet Alerts VVUS Hot Sheet
Trade VVUS Now!
Share of VIVUS Inc. (Nasdaq: VVUS) resume trading up 17% after the FDA approved obesity drug Qsymia.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- VIVUS, Inc. (VVUS) to Make Several Scientific Presentations in May
- Short Sellers See the Light (HLF) (FSLR) (NFLX) (TLSA)
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader Talk, Trading Halts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
